Categories
Anticancer Drugs Olaparib Oncology Pharmacology Physiotherapy

Olaparib (Dose Modifications-1)

In this article, we will discuss Olaparib (Dose Modifications-1). So, let’s get started.

  • Dose Modifications for Use with CYP3A Inhibitors
  • Avoid concomitant use of strong or moderate CYP3A inhibitors and consider alternative agents with less CYP3A inhibition. If a strong CYP3A inhibitor must be co-administered, reduce the Olaparib dose to 100 mg (one 100 mg tablet) taken twice daily (equivalent to a total daily dose of 200 mg). If a moderate
    CYP3A inhibitor must be co-administered, reduce the Olaparib dose to 150 mg (one 150 mg tablet) taken twice daily (equivalent to a total daily dose of 300 mg)

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Discover more from PT Master Guide

Subscribe now to keep reading and get access to the full archive.

Continue reading